Abstract
Elderly individuals experience a disproportionate burden from cardiovascular disease. Global changes in aging will have a significant impact on the future of medical practice. However, most physicians have little formal training in geriatric medicine and sometimes fail to distinguish disease states from normal aging. Increasingly, it is recognised that a sedentary lifestyle may be responsible for a large fraction of the so-called ‘age-related’ changes in the cardiovascular system. Nonetheless, well characterised changes do occur in most individuals with aging. Loss of myocytes with subsequent hypertrophy of the remaining cells is usually observed. Calcification involving the conduction and valvular apparatus is seen in most elderly individuals and may predispose to the common arrhythmias of old age. Age-related loss of arterial compliance contributes to isolated systolic hypertension and left ventricular hypertrophy.
Despite these changes, for the majority of healthy older adults, cardiac output is well maintained in the basal state through use of the Frank-Starling principle, in the setting of reduced early diastolic filling. Myocardial relaxation is slowed in part due to age-related changes in the sarcoplasmic reticulum Ca2+ ATPase pump. Elevated blood levels of catecholamines contribute to desensitisation to noradrenergic stimulation and this is associated with an age-related decline in maximum achievable heart rate. Changes in the baroreceptor reflex function and decreased sodium conservation may predispose some individuals to orthostatic and postprandial hypotension.
The aetiology of cardiovascular aging is under intense study. The most likely mechanisms involve the result of cumulative damage mediated through a variety of insults. Oxidative stress, non-enzymatic glycation, inflammation and changes in cardiovascular gene expression all seem to influence cardiovascular aging.
The benefits of exercise continue to be discovered. Endurance-type training has been shown to have a dramatic impact on parameters of cardiovascular aging. Favourable effects are seen in maximum oxygen consumption, diastolic filling, relaxation and arterial stiffness. Some changes such as the maximum heart rate response do not appear to change with conditioning. Pharmacotherapy may afford the opportunity to influence the aging process. Drugs that can reduce age-associated arterial stiffness, cardiac fibrosis and ventricular hypertrophy should prove useful. Antioxidants continue to be a topic of great interest and require more study.
Despite some well described changes with aging, most elderly individuals maintain the opportunity for improved cardiovascular function through conditioning. Early recognition and treatment of diseases that are distinguishable from normal aging, including hypertension and atherosclerosis, together with preventive efforts, should reduce the predicted trends in cardiovascular morbidity and mortality among the aged.
Similar content being viewed by others
References
Foot DK, Lewis RP, Pearson TA, et al. Demographics and cardiology, 1950–2050. J Am Coll Cardiol 2000; 35: 1067–81
Premen AJ. Research Recommendations for cardiovascular aging research. NIA Cardiovacular Aging Advisory Panel. J Am Geriatr Soc 1996; 44: 1114–7
Batchelor WB, Jollis JG, Friesinger GC. The challenges of health care delivery to the elderly patient with cardiovascular disease: demographic, epidemiologic, fiscal, and health policy implications. Cardiol Clin 1999; 17: 1–15
International Year of Older Persons. Available from URL: http://un.org/esa/socdev/iyop.htm [Accessed 2001 Feb 14]
Cassel CK. In defense of a department of geriatrics. Ann Intern Med 2000; 4: 297–301
Lakatta EG. Cardiovascular aging research: the next horizons. J Am Geriatr Soc 1999; 47: 613–25
Katzel LI, Fleg JL, Busby-Whitehead JM, et al. Exerciseinduced silent myocardial ischemia in master athletes. Am J Cardiol 1998; 81: 261–5
Olivetti G, Melissari M, Capasso JM, et al. Cardiomyopathy of the aging human heart: myocyte loss and reactive cellular hypertrophy. Circ Res 1991; 68; 1560–8
Wei JY. Age and the cardiovascular system. N Engl J Med 1992; 327: 1735–9
Olivetti G, Cigola E, Maestri R, et al. Recent advances in cardiac hypertrophy. Cardiovasc Res 2000; 45: 68–75
Hayward CS, Kelly RP, Collins P. The role of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res 2000; 46: 28–49
Goor D, Lillehei CW, Edwards JE. The sigmoid septum: variation in the contour of the left ventricular outlet. Am J Roentgenol Radium Ther Nucl Med 1969; 107: 366–76
Shapiro LM, Howat AP, Crean PA, et al. An echocardiographic study of localized subaortic hypertrophy. Eur Heart J 1986; 7: 127–32
Swinne CJ, Shapiro EP, Jamart J, et al. Age-associated changes in left ventricular outflow tract geometry in normal subjects. Am J Cardiol 1996; 76: 1070–3
Henein MY, O’Sullivan C, Sutton GC, et al. Stress-induced left ventricular outflow tract obstruction: a potential cause of dyspnea in the elderly. J Am Coll Cardiol 1997; 30: 1301–7
Barletta G, Del Bene MR, Gallini C, et al. The clinical impact of dynamic intraventricular obstruction during dobutamine stress echocardiography. Int J Cardiol 1999; 70: 179–89
Rehman HU. Age and the cardiovascular system. Hosp Med 1999; 60: 645–50
Lie JT, Hammond PI. Pathology of the senescent heart: anatomic observations on 237 autopsy studies of patients 90 to 105 years old. Mayo Clin Proc 1988; 63: 552–64
Roffe C. Ageing of the heart. Br J Biomed Sci 1998; 55: 136–48
Lakatta EG. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 1993; 73: 413–67
Roberts WC, Shirani J. Comparison of cardiac findings at necropsy in octogenarians, nonagenerains, and centenarians. Am J Cardiol 1998; 82: 627–31
Schulman SP. Cardiovascular consequences of the aging process. Cardiol Clin 1999; 17: 35–49
Smulyan H, Safar ME. Systolic blood pressure revisited. J Am Coll Cardiol 1997; 29: 1407–13
Blacher J, Staessen JA, Girerd X, et al. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med 2000; 160: 1805–9
O’Rourke MF, Mancia G. Arterial stiffness. J Hypertens 1999; 17: 1–4
Rajkumar C, Kingwell BA, Cameron JD, et al. Hormonal therapy increases arterial compliance in postmenopausal women. Atherosclerosis 1997; 30: 350–6
Van Bortel LM, Kool MJ, Spek JJ. Disparate effects of antihypertensive drugs on large artery distensibility and compliance in hypertension. Am J Cardiol 1995; 76(15): 46E–9E
Avolio AP, Clyde CM, Beard TC, et al. Improved arterial distensibility in normotensive subjects on a low salt diet. Arteriosclerosis 1986; 6: 166–9
Weinberg AD, Minaker KL. Dehydration: evaluation and management in older adults. Council on Scientific Affairs, American Medical Association. JAMA 1995; 274: 1552–6
Robert L. Aging of the vascular-wall and atherosclerosis. Exp Gerontol 1999; 34: 491–501
Marin J. Age-related changes in vascular responses: a review. Mech Ageing Dev 1995; 79: 71–114
Matz RL, Schott C, Stoclet JC, et al. Age-related endothelial dysfunction with respect to nitric oxide, endothelium-derived hyperpolarizing factor and cyclooxygenase products. Physiol Res 2000; 49: 11–8
Reaven PD, Napoli C, Merat S, et al. Lipoprotein modification and atherosclerosis in aging. Exp Gerontol 1999; 34: 4527–37
Van Lente F. Markers of inflammation as predictors in cardiovascular disease. Clin Chim Acta 2000; 293: 31–52
Gottdiener JS, Arnold AM, Aurigemma GP, et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000; 35: 1628–37
Kyne L, Hausdorff JM, Knight E, et al. Neutrophilia and congestive heart failure after acute myocardial infarction. Am Heart J 2000; 139: 94–100
Weisfeldt ML, Loeven WA, Shock NW. Resting and active mechanical properties of trabeculae carnae from aged male rats. Am J Physiol 1971; 220: 1921–7
Lómpre A. The sarco(endo)plasmic reticululum Ca2+-ATPases in the cardiovascular system during growth and proliferation. Trends Cardiovasc Med 1998; 8: 75–82
Bak MI, Wei JY, Ingwall JS. Interaction of hypoxia and aging in the heart: analysis of high energy phosphate content. J Mol Cell Cardiol 1998; 30: 661–72
Mandinov L, Eberli FR, Seiler C, et al. Diastolic heart failure. Cardiovasc Res 2000; 45: 813–25
Stratton JR, Cerqueira MD, Schwartz RS, et al. Differences in cardiovascular responses to isoproterenol in relation to age and exercise training in healthy men. Circulation 1992; 86: 504–12
Turner MJ, Mier CM, Spina RJ, et al. Effects of age and gender on cardiovascular responses to isoproterenol. J Gerontol A Biol Sci Med Sci 1999; 54: B393–400
Poller U, Nedelka G, Radke J, et al. Age-dependent changes in cardiac muscarinic receptor function in healthy volunteers. J Am Coll Cardiol 1997; 29: 187–93
Lipsitz LA. Orthostatic hypotension in the elderly. N Engl J Med 1989; 321: 952–7
Matsubayashi K, Okumiya K, Wada T, et al. Postural dysregulation in systolic blood pressure in associated with worsened scoring on neurobehavioral function tests and leukoariosis in the older elderly living in a community. Stroke 1997; 28: 2169–73
Jansen RW, Lipsitz LA. Postprandial hypotension: epidemiology, pathophysiology, and clinical management. Ann Intern Med 1995; 122: 286–95
Quyyumi AA. Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med 1998; 105(1A): 32S–9S
Andrawis N, Jones DS, Abernethy DR. Aging is associated with endothelial dysfunction in the human forearm vasculature. J Am Geriatr Soc 2000; 48: 193–8
Henderson A. Endothelial dysfunction: a reversible clinical measure of atherogenic susceptibility and cardiovascular inefficiency. Int J Cardiol 1997; 62Suppl. 1: S43–8
Virdis A, Ghiadoni L, Taddei S, et al. Vitamin C improves agerelated endothehal dysfunction in humans [abstract]. Hypertension 1998: 32: 791
Simons LA, von Konigsmark M, Simons J, et al. Vitamin E ingestion does not improve arterial endothelial dysfunction in older adults. Atherosclerosis 1999; 143: 193–9
Wick G, Perschinka H, Xu Q. Autoimmunity and atherosclerosis. Am Heart J 1999; 138 (5 Pt 2): S444–9
Muscari C, Giaccare A, Giordano E, et al. Role of reactive oxygen species in cardiovascular aging. Mol Cell Biochem 1996; 160/161: 159–66
Pryor W. Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med 2000; 28: 141–64
Weindruch R, Sohal RS. Seminars in medicine of the Beth Israel Deaconess Medical Center: caloric intake and aging. N Engl J Med 1997; 337: 986–94
Odiet JA, Wei JY. Heart failure and the aging myocardium: possible role of cardiac mitochondria. Heart Failure Rev 1996; 2: 139–49
Ferder L, Romano LA, Ercole LB, et al. Biomolecular changes in the aging myocardium: the effect of enalapril. Am J Hypertens 1998; 11: 1297–304
Bierhaus A, Hoffman MA, Zeigler R, et al. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res 1998; 37: 586–600
Corman B, Duriez M, Poitevin P, et al. Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy. Proc Natl Acad Sci U S A 1998; 95: 1301–6
MacLellan WR, Schneider MD. Death by design: programmed cell death in cardiovascular biology and disease. Circ Res 1997; 81: 137–44
Sabbah HN. Apoptotic cell death in heart failure. Cardiovasc Res 2000; 45: 704–12
Schmidt U, del Monte F, Miyamoto MI, et al. Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca2+-ATPase. Circulation 2000; 101: 790–6
Maharam LG, Bauman PA, Kalman D, et al. Masters athletes: factors affecting performance. Sports Med 1999; 4: 273–85
Andersen R, Christmas C. Exercise and older patients: guidelines for the clinician. J Am Geriatr Soc 2000; 48: 318–24
Schulman SP, Fleg JL, Goldberg AP, et al. Continium of cardiovascular performance across a broad range of fitness levels in healthy older men. Circulation 1996; 94: 359–67
Forman DE, Manning WJ, Hauser R, et al. Enhanced left ventricular diastolic filling associated with long-term endurance training. J Gerontol 1992; 47: M56–8
Wei JY, Li YX, Lincoln T, et al. Chronic exercise training protects aged cardiac muscle against hypoxia. J Clin Invest 1989; 83: 778–84
Bulpitt CJ, Rajkumar C, Cameron JD. Vascular compliance as a measure of biological age. J Am Geriatr Soc 1999; 47: 657–63
Chae CU, Pfeffer MA, Glynn RJ, et al. Increased pulse pressure and risk of heart failure in the elderly. JAMA 1999; 281: 634–49
Vaitkevicius PV, Fleg JL, Engel JH, et al. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation 1993: 88: 1456–62
Cameron JD, Dart AM. Exercise training increases total systemic arterial comphance in humans. Am J Physiol 1994; 266: H693–701
Spital A. Diuretic-induced hyponatremia. Am J Nephrol 1999; 19: 447–52
Willenheimer R. Left ventricular remodelling and dysfunction: can the process be prevented? Int J Cardiol 2000; 72: 143–50
Delcayre C, Silvestre JS. Aldosterone and the heart: towards a physiological function? Cardiovasc Res 1999; 43: 7–12
Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study investigators. N Engl J Med 1999; 341: 709–17
Paulus WJ, Shah AM. NO and cardiac diastolic function. Cardiovasc Research 1999; 43: 595–606
Acknowledgements
Supported in part by HHS grants AG08812, AG13314, and AG18388. Lieutenant-Commander Pugh was supported by the US Navy, Naval School of Health Sciences, Bethesda, Maryland, USA
Author information
Authors and Affiliations
Corresponding author
Additional information
The views expressed in this article are those of the author and do not reflect the official policy or position of the Department of the Navy, Department of Defense or the US Government.
Rights and permissions
About this article
Cite this article
Pugh, K.G., Wei, J.Y. Clinical Implications of Physiological Changes in the Aging Heart. Drugs & Aging 18, 263–276 (2001). https://doi.org/10.2165/00002512-200118040-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-200118040-00004